secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acadia Healthcare Company, Inc. (ACHC)
CIK:        0001520697
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0001157523-22-001443
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acadia Healthcare Q3 2022: revenue up 13.5%, adj. EPS $0.86, narrows FY guidance
--------------------------------------------------------------------------------

- Revenue $666.7M (+13.5% YoY); same-facility revenue +10.2% on 6.9% revenue/patient day and 3.1% patient day growth.
- Net income $71.1M ($0.78 diluted EPS); adjusted EPS $0.86 (incl. $0.06 from PRF); ex-PRF adj. EPS $0.80.
- Adjusted EBITDA $162.8M (incl. $7.7M PRF); ex-PRF $155.1M; net leverage ratio ~2.1x; $515M revolver available.
- Narrowed 2022 guidance: revenue $2.58-2.60B; Adj. EBITDA (excl. PRF) $595-605M; Adj. EPS $3.00-3.10 (excl. PRF).
- Added 132 beds in Q3, opened 60-bed children's hospital in Chicago and 2 CTCs; on track for ~300 beds in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520697/000115752322001443/0001157523-22-001443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520697/000115752322001443/a52956469.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-001443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer